# The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)

> **NCT00974181** · PHASE3 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 282 (actual)

## Conditions studied

- Treatment of Symptomatic Ischemic Heart Disease

## Interventions

- **DEVICE:** Conor Medsystems COSTAR™ stent (10 µg Paclitaxel)
- **DEVICE:** Conor Medsystems COSTAR™ stent (30 µg Paclitaxel)

## Key facts

- **NCT ID:** NCT00974181
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2005-05
- **Final completion:** 2010-03
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2010-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974181, "The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00974181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*